Author:
Guan Li,Li Aiyun,Song Pengfei,Su Wanzhen,Zhang Shengjie,Chen Jiaxin,Jiao Xiangying,Li Weize
Funder
Xi'an Medical University
Shanxi Medical University
Reference31 articles.
1. Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action;Thielen;Cell Metab.,2020
2. Brussels, Belgium, International Diabetes Federation, IDF Diabetes Atlas, 10th Edition, International Diabetes Federation, 2021.
3. P. Wang, E. Karakose, C. Argmann, H. Wang, M. Balev, R.I. Brody, H.G. Rivas, X.Y. Liu, O. Wood, H.T. Liu, L. Choleva, D. Hasson, E. Bernstein, J.A. Paulo, D.K. Scott, L. Lambertini, J.A. DeCaprio, A.F. Stewart, Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells. J. Clin. Invest. (132) 2022 e157086.
4. DYRK1A inhibitors as potential therapeutics for β-cell regeneration for diabetes;Kumar;J. Med. Chem.,2021
5. TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives;Li;J. Enzyme Inhib. Med. Chem.,2023